Țară: Țările de Jos
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
detomidine hydrochloride 10 mg/ml
Vetcare Limited
QN05CM90
Solution for injection
Detomidine
Horses
2012-02-16
Revised: August 2013 AN: 00202/2012 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DETOGESIC 10 mg/ml Solution for Injection for Horses BE, BG, CY, CZ, DE, EL, ES, FR, IE, IT, LU, NL, PL, PT, RO, SI, SK, UK EQUISEDAN vet 10 mg/ml Solution for Injection for Horses FI, NO, SE EQUISEDAN 10mg/ml Solution for Injection for Horses DK, LT. LV EQUIDOR 10mg/ml Solution for Injection for Horses AT, HU 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Detomidine hydrochloride 10 mg/ml (Detomidine 8.36 mg/ml) EXCIPIENT(S): Preservative Methyl parahydroxybenzoate (E218) 1 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection. Clear, almost colourless solution for intravenous injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horse 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the sedation and slight analgesia of horses, to facilitate physical examinations and treatments, such as minor surgical interventions. The product can be used for: Medical examinations (e.g. endoscopic, rectal and gynaecological examinations, X-rays). Minor surgical procedures (e.g. treatment of wounds, dental treatment, tendon treatment, excision of skin tumours, teat treatment). Before treatment and medication (e.g. stomach tube, horse shoeing). For pre-medication prior to administration of injection or inhalation anaesthetics. See section 4.5 before use. Revised: August 2013 AN: 00202/2012 Page 2 of 7 4.3 CONTRAINDICATIONS Do not use in Citiți documentul complet